For Research Use Only. We do not provide direct services or products for patients.
Imdevimab is a recombinant monoclonal antibody that targets the SARS-CoV-2 surface spike protein receptor binding domain.
Recombinant SARS-CoV-2 RBD protein
PBS, pH 7.5.
Used for WB, ELISA, IHC-P, FCM, ICC/IF, IP.
Store at 2°C to 8°C short term, -20°C long term.
Imdevimab is a monoclonal antibody combined with casirivimab in Regeneron's antibody cocktail known as REGEN-COV2 for the treatment of COVID-19.8 This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19.2 These antibodies have been formulated to bind to multiple locations on the SARS-COV-2 spike protein, preventing viral escape.